{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:28Z","timestamp":1707525028306},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,3]]},"DOI":"10.7759\/cureus.38506","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T21:51:15Z","timestamp":1683150675000},"source":"Crossref","is-referenced-by-count":0,"title":["Immune Reconstitution Inflammatory Syndrome Reaction in Patient on Long-Term Prednisone"],"prefix":"10.7759","author":[{"given":"Savina","family":"Sahgal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivanjali","family":"Shankaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200205000-00005","article-title":"Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy","volume":"81","author":"Shelburne SA 3rd","year":"2002","unstructured":"Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, et al.. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore). 2002, 81:213-27. 10.1097\/00005792-200205000-00005","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/3.3.422","article-title":"The immunology of leprosy: speculations on the leprosy spectrum","volume":"3","author":"Sansonetti P","year":"1981","unstructured":"Sansonetti P, Lagrange PH. The immunology of leprosy: speculations on the leprosy spectrum. Rev Infect Dis. 1981, 3:422-69. 10.1093\/clinids\/3.3.422","journal-title":"Rev Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/life10110262","article-title":"Tuberculosis IRIS: pathogenesis, presentation, and management across the spectrum of disease","volume":"10","author":"Quinn CM","year":"2020","unstructured":"Quinn CM, Poplin V, Kasibante J, Yuquimpo K, Gakuru J, Cresswell FV, Bahr NC. Tuberculosis IRIS: pathogenesis, presentation, and management across the spectrum of disease. Life (Basel). 2020, 10:262. 10.3390\/life10110262","journal-title":"Life (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2016.03.002","article-title":"Tuberculosis-immune reconstitution inflammatory syndrome","volume":"3","author":"Lanzafame M","year":"2016","unstructured":"Lanzafame M, Vento S. Tuberculosis-immune reconstitution inflammatory syndrome. J Clin Tuberc Other Mycobact Dis. 2016, 3:6-9. 10.1016\/j.jctube.2016.03.002","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32832d7aff","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients","volume":"22","author":"Sun HY","year":"2009","unstructured":"Sun HY, Singh N. Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients. Curr Opin Infect Dis. 2009, 22:394-402. 10.1097\/QCO.0b013e32832d7aff","journal-title":"Curr Opin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan U","year":"2013","unstructured":"Mahadevan U, Wolf DC, Dubinsky M, et al.. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013, 11:286-92. 10.1016\/j.cgh.2012.11.011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.8.718","article-title":"Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology","volume":"61","author":"Buttgereit F","year":"2002","unstructured":"Buttgereit F, da Silva JA, Boers M, et al.. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis. 2002, 61:718-22. 10.1136\/ard.61.8.718","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-84-3-304","article-title":"Glucocorticosteroid therapy: mechanisms of action and clinical considerations","volume":"84","author":"Fauci AS","year":"1976","unstructured":"Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976, 84:304-15. 10.7326\/0003-4819-84-3-304","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6369.923","article-title":"Rifampicin reduces effectiveness and bioavailability of prednisolone","volume":"286","author":"McAllister WA","year":"1983","unstructured":"McAllister WA, Thompson PJ, Al-Habet SM, Rogers HJ. Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed). 1983, 286:923-5. 10.1136\/bmj.286.6369.923","journal-title":"Br Med J (Clin Res Ed)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/145868-immune-reconstitution-inflammatory-syndrome-reaction-in-patient-on-long-term-prednisone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:26Z","timestamp":1707508706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/145868-immune-reconstitution-inflammatory-syndrome-reaction-in-patient-on-long-term-prednisone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.38506","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,3]]}}}